Delivery Order SPE2DB22D2009-SPE2DB25FL7SV

Award Date 2/5/25
Potential Completion Date 2/6/25
Potential Value $5.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,591.28 firm fixed-price delivery order is for the supply of 4,566,328,918 units of TERIPARATIDE 600 MCG/2.4ML PEN 2.4ML, a specialty medication. The contract has an ultimate completion date of November 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $6,484.91, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Firm Fixed Price Delivery Order for the supply of 4,566,847,548 units of the medication TERIPARATIDE 600 MCG/2.4ML PEN 2.4ML. The contract has an ultimate completion date of January 7, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,818.55 firm fixed-price delivery order is for the supply of 4,566,529,507 units of Teriparatide 600 mcg/2.4 ml injection pens. The contract has an ultimate completion date of November 25, 2024 and was awarded on November 22, 2024. Amerisourcebergen holds a significant $999,999,999...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,383,566 units of teriparatide 600 mcg/2.4 ml pens. The $5,439.01 firm fixed-price delivery order has a ceiling value and an ultimate completion date of November 12, 2024. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,502.81 firm fixed price delivery order is for 4,566,975,783 units of teriparatide 600 mcg/2.4 ml pen, with a performance period through January 21, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order (Order) valued at $5,182.62. The Order was issued by the Defense Logistics Agency (DLA) and is for the supply of teriparatide, a specialty injectable medication used to treat osteoporosis. The Order has a Firm Fixed Price pricing type and a completion date of July 25, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corporation, a wholly owned subsidiary of Amerisourcebergen Corporation, to provide 4,563,927,592 units of the pharmaceutical product Teriparatide 600 mcg/2.4ml pen at a ceiling value of $2,299.97. The award, which has an ultimate completion date of March 12, 2024, is part of a larger indefinite delivery contract (IDC) valued up to...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $29,830.25 firm fixed-price delivery order is for the supply of 4,566,054,436 units of the drug Teriparatide 600 mcg/2.4 ml pen. The contract has an ultimate completion date of October 9, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
This federal contract award, valued at $7,705.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of 4564630664 - TERIPARATIDE 600 MCG/2.4ML PEN 2.4ML. This is a firm fixed-price Delivery Order contract with a completion date of May 17, 2024. Amerisourcebergen Drug Corp, a subsidiary of the larger Amerisourcebergen Corporation, is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the...
This federal contract award, identified as SPE2DB22D1002|SPE2DB25FKUZ7, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,678.19 firm fixed-price delivery order is for the supply of 4,566,597,194 units of the medication teriparatide 600 mcg/2.4 ml pen. This award does not have a set-aside designation, indicating open competition. The contract is a delivery order placed under...
  • SPE2DB22D2009
    Indefinite Delivery Contract
  • SPE2DB22D2009-SPE2DB25FL7SV
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,510.61 firm-fixed-price delivery order is for the supply of 4567171361 - TERIPARATIDE 600 MCG/2.4ML PEN 2.4ML. The contract has a period of performance through February 6, 2025.

Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

This contract award does not have a set-aside designation, indicating open competition. As a major supplier to federal government agencies, particularly within military and veterans' healthcare systems, Amerisourcebergen plays a critical role in delivering essential pharmaceutical and medical commodities to support the healthcare needs of federal beneficiaries.

Generated 5/7/25, 9:54 AM